Deutsche Bank Ag\ Nemaura Medical Inc. Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$4.7 - $16.7 $22,560 - $80,160	-4,800 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$3.79 - $9.78 $1,705 - $4,401	-450 Reduced 8.57%	4,800 $36,000
Q4 2020 Feb 16, 2021	BUY	$3.47 - $4.52 $6,381 - $8,312	1,839 Added 53.91%	5,250 $20,000
Q3 2020 Nov 12, 2020	BUY	$3.55 - $9.99 $1,128 - $3,176	318 Added 10.28%	3,411 $12,000
Q2 2020 Aug 13, 2020	BUY	$4.75 - $15.38 $14,691 - $47,570	3,093 New	3,093 $29,000
Q1 2020 May 14, 2020	SELL	$2.85 - $8.0 $855 - $2,400	-300 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.31 - $8.0 $993 - $2,400	300 New	300 $1,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Market Cap $723K
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.